Microfluidics, BioMEMS, and Medical Microsystems IX 2011
DOI: 10.1117/12.881082
|View full text |Cite
|
Sign up to set email alerts
|

PharmaSat: drug dose response in microgravity from a free-flying integrated biofluidic/optical culture-and-analysis satellite

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 0 publications
0
19
0
Order By: Relevance
“…First fully automated self-contained biological experiment to fly on a CubeSat; proved that scientists can design and launch a new class of inexpensive spacecraft, and conduct significant science in space PharmaSat Organism: Saccharomyces cerevisiae (budding yeast); provided life support, growth monitoring, and analysis capabilities for yeast in a 48-well microfluidic card; tracked growth by optical density, metabolism with alamarBlue metabolic indicator dye, and the effects of microgravity on yeast susceptibility to antifungal drugs; findings: slower yeast growth in microgravity. At low doses of antifungal, no differences were observed between flight and ground samples; however, significant metabolic activity still observed at higher dose in microgravity (Ricco et al, 2011).…”
Section: Missionmentioning
confidence: 81%
See 1 more Smart Citation
“…First fully automated self-contained biological experiment to fly on a CubeSat; proved that scientists can design and launch a new class of inexpensive spacecraft, and conduct significant science in space PharmaSat Organism: Saccharomyces cerevisiae (budding yeast); provided life support, growth monitoring, and analysis capabilities for yeast in a 48-well microfluidic card; tracked growth by optical density, metabolism with alamarBlue metabolic indicator dye, and the effects of microgravity on yeast susceptibility to antifungal drugs; findings: slower yeast growth in microgravity. At low doses of antifungal, no differences were observed between flight and ground samples; however, significant metabolic activity still observed at higher dose in microgravity (Ricco et al, 2011).…”
Section: Missionmentioning
confidence: 81%
“…Other notable biological CubeSats followed, with the launch of PharmaSat in 2009, and O/OREOS (Organism/Organic Exposure to Orbital Stresses) in 2010, which built upon GeneSat-1's experimental and technical heritage. PharmaSat contained optical sensor systems to detect the growth, density, and health of yeast cells and examined how yeast responded to an antifungal treatment, elucidating changes to drug action in space (Ricco et al, 2011). O/OREOS contained two experiment payloads, SEVO (space environment viability of organics) and SESLO (space environment survivability of living organisms).…”
Section: Nasa's Biological Cubesatsmentioning
confidence: 99%
“…R8755), buffered with 0.1 M 3-(N-morpholino) propanesulfonic acid (MOPS, pH 7.0) and containing the redox dye alamarBlue (aB, the chemical name of which is resazurin) (Invitrogen, Carlsbad, CA, USA) added at a 1:25 dilution of the stock solution [13]. While not a standard B. subtilis growth medium, the RPMI 1640 formulation described above had previously been tested for stability and biocompatibility and was used successfully to cultivate S. cerevisiae in the prior PharmaSat experiment [11,12]. Pre-flight testing of the medium showed it also supported B. subtilis growth well, so it was used for the SESLO experiment.…”
Section: Methodsmentioning
confidence: 99%
“…Building on the design of GeneSat-1, a second 3U nanosat mission called PharmaSat was launched as a secondary payload from NASA's Wallops Flight Facility on a Minotaur I rocket on 19 May 2009 and was placed into a 459-km, 40.4 • -inclination orbit [11]. The objectives of the PharmaSat mission were to cultivate the yeast Saccharomyces cerevisiae in space and to compare its level of resistance to the antifungal agent voriconazole in space vs. matched ground control samples [11,12]. Comparison of the optically measured results for the zero-voriconazole-dose microwells in microgravity with those on the ground revealed a longer "lag time" for the spaceflight yeast than the ground specimens, whether measured by cell density (turbidimetry) or metabolism (alamarBlue reduction).…”
Section: Introductionmentioning
confidence: 99%
“…An overview of these small satellites can be seen in Table 2 . PharmaSat launched in 2009 and utilized a three-LED optical sensor to monitor microbial activity, this time testing yeast cells and their response to a fungicide in microgravity [ 27 ]. In 2010, Organism/Organic Exposure to Orbital Stresses (O/OREOS) successfully integrated two independent astrobiology studies in one CubeSat [ 28 ].…”
Section: Biological Cubesat Missionsmentioning
confidence: 99%